BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 11681242)

  • 1. [Paclitaxel].
    Omuro Y; Sasaki T
    Gan To Kagaku Ryoho; 2001 Oct; 28(10):1357-62. PubMed ID: 11681242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paclitaxel dose intensity.
    Reed E; Bitton R; Sarosy G; Kohn E
    J Infus Chemother; 1996; 6(2):59-63. PubMed ID: 8809650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-agent paclitaxel in the treatment of breast cancer: phase I and II development.
    Seidman AD
    Semin Oncol; 1999 Jun; 26(3 Suppl 8):14-20. PubMed ID: 10403469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paclitaxel in Breast Cancer.
    Perez EA
    Oncologist; 1998; 3(6):373-389. PubMed ID: 10388129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Weekly Taxol (Paclitaxel) administration in the second-line treatment of breast cancer].
    Dank M
    Magy Onkol; 2002; 46(2):189-91. PubMed ID: 12202898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Weekly administration of paclitaxel in the treatment of metastatic breast cancer: from rational to practice].
    Campone M; Fumoleau P
    Bull Cancer; 2002 Mar; 89(3):275-82. PubMed ID: 11940467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feasibility and therapeutic efficacy of weekly 1-h low-dose paclitaxel infusion for relapsed breast cancer.
    Kim R; Osaki A; Toge T
    Oncol Rep; 2003; 10(1):145-50. PubMed ID: 12469161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Weekly administration of low-dose paclitaxel for advanced or metastatic breast cancer].
    Uno Y; Hirano M; Murakami N; Kikuchi T; Nozawa H; Okuda T; Oya J; Kikkawa H
    Gan To Kagaku Ryoho; 2002 Feb; 29(2):227-32. PubMed ID: 11865628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A simplified premedication schedule for 1-hour paclitaxel administration.
    Tsavaris N; Kosmas C; Vadiaka M
    J Support Oncol; 2005; 3(1):77-81. PubMed ID: 15724950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II study of weekly paclitaxel for advanced or metastatic breast cancer in Japan.
    Horiguchi J; Rai Y; Tamura K; Taki T; Hisamatsu K; Ito Y; Seriu T; Tajima T
    Anticancer Res; 2009 Feb; 29(2):625-30. PubMed ID: 19331212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Weekly paclitaxel therapy for metastatic breast cancer].
    Kokufu I; Taniguchi H; Kimura F; Fukuda K; Yamamoto M; Yano T; Yamada K
    Gan To Kagaku Ryoho; 2002 Feb; 29(2):221-6. PubMed ID: 11865627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose-intense paclitaxel: deja vu all over again?
    Takimoto CH; Rowinsky EK
    J Clin Oncol; 2003 Aug; 21(15):2810-4. PubMed ID: 12807932
    [No Abstract]   [Full Text] [Related]  

  • 13. [Weekly paclitaxel administration in the adjuvant therapy of primary breast cancer].
    Takahashi H; Takahashi M; Taguchi K; Sasaki F; Todo S
    Gan To Kagaku Ryoho; 2003 May; 30(5):653-9. PubMed ID: 12795097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neoadjuvant paclitaxel for operable breast cancer: multicenter phase II trial with clinical outcomes.
    Kimura M; Sano M; Fujimori M; Nakagomi H; Negishi T; Yanagita Y; Sato N
    Anticancer Res; 2008; 28(2B):1239-44. PubMed ID: 18505061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Relation of dose intensity and efficacy, toxicity in paclitaxel as a single agent for advanced breast cancer].
    Liu F; Jiang ZF; Song ST; Liu XQ; Wang T; Yan M; Zhang SH; Hao CF; Sun JZ; Shen G
    Zhonghua Zhong Liu Za Zhi; 2005 Jan; 27(1):56-8. PubMed ID: 15771802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical study of weekly paclitaxel administration for metastatic breast cancer based on time to progression (TTP) and survival].
    Emoto T; Yoshikawa K; Yoshioka Y; Nezu R; Fujikawa M; Fujii M; Maeda S; Naka Y; Komaki T
    Gan To Kagaku Ryoho; 2003 Jun; 30(6):817-22. PubMed ID: 12852349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Weekly paclitaxel and 5-fluorouracil in pretreated patients with metastatic breast cancer: a phase I study.
    Cortesi E; Grifalchi F; Ramponi S; Padovani A; Mancuso A; Paoluzzi L; Ferrau F; Oliva A
    Anticancer Res; 2003; 23(2C):1961-6. PubMed ID: 12820487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Weekly paclitaxel and carboplatin with concurrent radiation therapy in locally advanced non-small cell lung cancer: phase I study.
    Endo M; Takada Y; Obayashi K; Kotani Y; Satouchi M; Kado T; Sugimura K
    Radiat Med; 2005 Aug; 23(5):331-5. PubMed ID: 16342905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II study of weekly paclitaxel as second-line therapy in patients with advanced non-small cell lung cancer.
    Ceresoli GL; Gregorc V; Cordio S; Bencardino KB; Schipani S; Cozzarini C; Bordonaro R; Villa E
    Lung Cancer; 2004 May; 44(2):231-9. PubMed ID: 15084388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Failure of higher-dose paclitaxel to improve outcome in patients with metastatic breast cancer: cancer and leukemia group B trial 9342.
    Winer EP; Berry DA; Woolf S; Duggan D; Kornblith A; Harris LN; Michaelson RA; Kirshner JA; Fleming GF; Perry MC; Graham ML; Sharp SA; Keresztes R; Henderson IC; Hudis C; Muss H; Norton L
    J Clin Oncol; 2004 Jun; 22(11):2061-8. PubMed ID: 15169793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.